139 related articles for article (PubMed ID: 36706620)
1. Discovery of multi-target directed 3-OH pyrrolidine derivatives through a semisynthetic approach from alkaloid vasicine for the treatment of Alzheimer's disease.
Bhanukiran K; T A G; Krishnamurthy S; Singh SK; Hemalatha S
Eur J Med Chem; 2023 Mar; 249():115145. PubMed ID: 36706620
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Multitarget-Directed Ligands from Piperidine Alkaloid Piperine as a Cap Group for the Management of Alzheimer's Disease.
Bhanukiran K; Singh SK; Singh R; Kumar A; Hemalatha S
ACS Chem Neurosci; 2023 Aug; 14(15):2743-2760. PubMed ID: 37433759
[TBL] [Abstract][Full Text] [Related]
3. Discovery of novel series of 2-substituted benzo[d]oxazol-5-amine derivatives as multi-target directed ligands for the treatment of Alzheimer's disease.
Gutti G; Kakarla R; Kumar D; Beohar M; Ganeshpurkar A; Kumar A; Krishnamurthy S; Singh SK
Eur J Med Chem; 2019 Nov; 182():111613. PubMed ID: 31437780
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of ferulic acid based 1,3,4-oxadiazole hybrids as multifunctional therapeutics for the treatment of Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Saraf P; Shrivastava SK
Bioorg Chem; 2020 Jan; 95():103506. PubMed ID: 31887472
[TBL] [Abstract][Full Text] [Related]
5. Lead optimization based design, synthesis, and pharmacological evaluation of quinazoline derivatives as multi-targeting agents for Alzheimer's disease treatment.
Verma A; Waiker DK; Singh N; Singh A; Saraf P; Bhardwaj B; Kumar P; Krishnamurthy S; Srikrishna S; Shrivastava SK
Eur J Med Chem; 2024 May; 271():116450. PubMed ID: 38701714
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and multitargeted profiling of N-benzylpyrrolidine derivatives for the treatment of Alzheimer's disease.
Choubey PK; Tripathi A; Sharma P; Shrivastava SK
Bioorg Med Chem; 2020 Nov; 28(22):115721. PubMed ID: 33007563
[TBL] [Abstract][Full Text] [Related]
7. Design and development of molecular hybrids of 2-pyridylpiperazine and 5-phenyl-1,3,4-oxadiazoles as potential multifunctional agents to treat Alzheimer's disease.
Tripathi A; Choubey PK; Sharma P; Seth A; Tripathi PN; Tripathi MK; Prajapati SK; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Dec; 183():111707. PubMed ID: 31561043
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Investigation of Quinazoline Derivatives as Multitargeting Therapeutics in Alzheimer's Disease Therapy.
Verma A; Waiker DK; Singh N; Roy A; Singh N; Saraf P; Bhardwaj B; Krishnamurthy S; Trigun SK; Shrivastava SK
ACS Chem Neurosci; 2024 Feb; 15(4):745-771. PubMed ID: 38327209
[TBL] [Abstract][Full Text] [Related]
9. Novel inhibitors of AChE and Aβ aggregation with neuroprotective properties as lead compounds for the treatment of Alzheimer's disease.
Liu Y; Uras G; Onuwaje I; Li W; Yao H; Xu S; Li X; Li X; Phillips J; Allen S; Gong Q; Zhang H; Zhu Z; Liu J; Xu J
Eur J Med Chem; 2022 May; 235():114305. PubMed ID: 35339839
[TBL] [Abstract][Full Text] [Related]
10. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
[TBL] [Abstract][Full Text] [Related]
11. Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease.
Gutti G; Leifeld J; Kakarla R; Bajad NG; Ganeshpurkar A; Kumar A; Krishnamurthy S; Klein-Schmidt C; Tapken D; Hollmann M; Singh SK
Eur J Med Chem; 2023 Nov; 259():115670. PubMed ID: 37515920
[TBL] [Abstract][Full Text] [Related]
12. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
[TBL] [Abstract][Full Text] [Related]
13. Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Cheng X; Zhu G; Wei R; Ma Q; Yu L; Zhao Y; Tan Z; Liu W
Eur J Med Chem; 2020 Feb; 187():111958. PubMed ID: 31865014
[TBL] [Abstract][Full Text] [Related]
14. Development of genistein-O-alkylamines derivatives as multifunctional agents for the treatment of Alzheimer's disease.
Sang Z; Shi J; Zhou Y; Wang K; Zhao Y; Li Q; Qiao Z; Wu A; Tan Z; Liu W
Bioorg Chem; 2021 Feb; 107():104602. PubMed ID: 33453647
[TBL] [Abstract][Full Text] [Related]
15. Design and development of multitarget-directed N-Benzylpiperidine analogs as potential candidates for the treatment of Alzheimer's disease.
Sharma P; Tripathi A; Tripathi PN; Prajapati SK; Seth A; Tripathi MK; Srivastava P; Tiwari V; Krishnamurthy S; Shrivastava SK
Eur J Med Chem; 2019 Apr; 167():510-524. PubMed ID: 30784883
[TBL] [Abstract][Full Text] [Related]
16. Novel hydroxybenzylamine-deoxyvasicinone hybrids as anticholinesterase therapeutics for Alzheimer's disease.
Bowroju SK; Penthala NR; Lakkaniga NR; Balasubramaniam M; Ayyadevara S; Shmookler Reis RJ; Crooks PA
Bioorg Med Chem; 2021 Sep; 45():116311. PubMed ID: 34304133
[TBL] [Abstract][Full Text] [Related]
17. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
18. The development of advanced structural framework as multi-target-directed ligands for the treatment of Alzheimer's disease.
Sang Z; Wang K; Shi J; Liu W; Cheng X; Zhu G; Wang Y; Zhao Y; Qiao Z; Wu A; Tan Z
Eur J Med Chem; 2020 Apr; 192():112180. PubMed ID: 32131034
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Potential of Novel Multi-Targeted Isoalloxazine Derivatives in Rodent Models of Alzheimer's Disease Through Activation of Canonical Wnt/β-Catenin Signalling Pathway.
Machhi J; Sinha A; Patel P; Kanhed AM; Upadhyay P; Tripathi A; Parikh ZS; Chruvattil R; Pillai PP; Gupta S; Patel K; Giridhar R; Yadav MR
Neurotox Res; 2016 May; 29(4):495-513. PubMed ID: 26797524
[TBL] [Abstract][Full Text] [Related]
20. New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and β-Amyloid aggregation for treatment of Alzheimer's disease.
El-Sayed NF; El-Hussieny M; Ewies EF; Fouad MA; Boulos LS
Bioorg Chem; 2020 Jan; 95():103499. PubMed ID: 31838287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
